Nicolas Joubert

7PUBLICATIONS
23CO-AUTHORS
Metal cluster chemistryCancer therapy (excl. chemotherapy and radiation therapy)GlycoconjugatesCharacterisation of biological macromoleculesBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 01, 2026
Modular CuAAC-Based Synthesis of C-Functional Cyclam-Picolinate Chelators for Antibody Conjugation.

Cédric Ollier, Dyhia Amrane, Guillaume Gabant

|Sep 05, 2025
Development of Optimized Exatecan-Based Immunoconjugates with Potent Antitumor Efficacy in HER2-Positive Breast Cancer.

Etienne Auvert, Emmanuel Douez, Louis Jolivet

|Jul 27, 2022
Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment-Drug Conjugates (FDCs).

Louis Jolivet, Imène Ait Mohamed Amar, Catherine Horiot

|Sep 28, 2021
Pharmacological Characterization of Low Molecular Weight Biased Agonists at the Follicle Stimulating Hormone Receptor.

Francesco De Pascali, Mohammed Akli Ayoub, Riccardo Benevelli

|Jul 02, 2021
Internalization of Foldamer-Based DNA Mimics through a Site-Specific Antibody Conjugate to Target HER2-Positive Cancer Cells.

Valentina Corvaglia, Imène Ait Mohamed Amar, Véronique Garambois

|Sep 17, 2020
Antibody-Drug Conjugates: The Last Decade.

Nicolas Joubert, Alain Beck, Charles Dumontet

Pageof 2